Fig. 1From: Pharmaceutical expenditure on drugs for rare diseases in Canada: a historical (2007–13) and prospective (2014–18) MIDAS sales data analysis2007–2013 Orphan Drug Expenditure out of Total Canadian Drug ExpenditureBack to article page